<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
         xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-11-03T23:10:53Z</responseDate>
  <request verb="GetRecord" identifier="oai:jmvra.org:JMVRA2610012" metadataPrefix="oai_dc">https://jmvra.org/oai.php</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:jmvra.org:JMVRA2610012</identifier>
        <datestamp>2026-10-03</datestamp>
        <setSpec>vol4</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
                   xmlns:dc="http://purl.org/dc/elements/1.1/"
                   xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
                   xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Global pharmacovigilance today: international programmes, emerging technologies and challenges in medicine safety</dc:title>
          <dc:creator>Rushikesh Rohidas Rawate</dc:creator>
          <dc:subject>Pharmacovigilance (PV)</dc:subject>
          <dc:subject>Adverse Drug Reaction (ADR)</dc:subject>
          <dc:subject>Monitoring Medicines (MM)</dc:subject>
          <dc:subject>World Health Organisation (WHO)</dc:subject>
          <dc:subject>Food and Drug Administration(FDA)</dc:subject>
          <dc:subject>Pharmacy All</dc:subject>
          <dc:description>This review discusses global pharmacovigilance programmes and their importance in ensuring medicine safety. It covers major international initiatives, adverse drug reaction reporting systems, collaboration between regulatory authorities, and pharmacovigilance practices in selected ASEAN countries. It also explores emerging technologies such as artificial intelligence, real-world data, and digital reporting tools, while highlighting challenges including under-reporting, limited resources, and difficulties in international data sharing. The review emphasises the need for stronger collaboration, improved reporting systems, and patient involvement to enhance medicine safety worldwide.</dc:description>
          <dc:publisher>JMVRA Publication</dc:publisher>
          <dc:date>2026-10-03</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal Article</dc:type>
          <dc:type>info:eu-repo/semantics/article</dc:type>
          <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
          <dc:format>application/pdf</dc:format>
          <dc:identifier>https://jmvra.org/viewpaperforall.php?paper=JMVRA2610012</dc:identifier>
          <dc:identifier>https://jmvra.org/papers/JMVRA2610012.pdf</dc:identifier>
          <dc:source>Journal of Modern and Versatile Research Approach; ISSN 2984-8911; Vol. 4; Issue 10; pp. a119-a133</dc:source>
          <dc:language>en</dc:language>
          <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
          <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
          <dc:rights>Copyright © 2026 The Author(s). Published by JMVRA Publication under the Creative Commons Attribution 4.0 International License (CC BY 4.0).</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>